These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

55 related items for PubMed ID: 8533445

  • 1. [Thrombomodulin is a marker of microvascular, but not for macrovascular endothelial cell damage].
    Sernau T, Wilhelm C, Seyfert U, Gabath S, Henkels M, Amiral J, Bergis KH, Ziegler R, Wahl P, Nawroth PP.
    Vasa; 1995; 24(4):347-53. PubMed ID: 8533445
    [Abstract] [Full Text] [Related]

  • 2. Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus.
    Gabat S, Keller C, Kempe HP, Amiral J, Ziegler R, Ritz E, Bergis KH, Wahl P, Nawroth P.
    Vasa; 1996; 25(3):233-41. PubMed ID: 8795304
    [Abstract] [Full Text] [Related]

  • 3. [Modification of hemorheological parameters in microvascular complications of diabetes].
    Bauduceau B, Renaudeau C, Mayaudon H, Hélie C, Ducorps M, Sonnet E, Yvert JP.
    Diabete Metab; 1995 Jun; 21(3):188-93. PubMed ID: 7556810
    [Abstract] [Full Text] [Related]

  • 4. Serum thrombomodulin as a marker of diabetic macroangiopathy.
    Matsuoka T, Yamasaki Y, Watarai T, Kubota M, Kamada T.
    Diabetes Care; 1995 May; 18(5):731. PubMed ID: 8586015
    [No Abstract] [Full Text] [Related]

  • 5. Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus.
    Zumbach M, Hofmann M, Borcea V, Luther T, Kotzsch M, Müller M, Hergesell O, Andrassy K, Ritz E, Ziegler R, Wahl P, Nawroth PP.
    Exp Clin Endocrinol Diabetes; 1997 May; 105(4):206-12. PubMed ID: 9285207
    [Abstract] [Full Text] [Related]

  • 6. [Thrombomodulin as endothelial cell marker in heart surgery patients].
    Böhrer H, Böttiger BW, Haussmann R, Nawroth PP, Motsch J, Martin E.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1995 Nov; 30(7):417-9. PubMed ID: 8562716
    [Abstract] [Full Text] [Related]

  • 7. Elevated serum and urinary thrombomodulin levels in patients with non-insulin-dependent diabetes mellitus.
    Shimano H, Takahashi K, Kawakami M, Gotoda T, Harada K, Shimada M, Yazaki Y, Yamada N.
    Clin Chim Acta; 1994 Mar; 225(2):89-96. PubMed ID: 8088010
    [Abstract] [Full Text] [Related]

  • 8. Plasma homocysteine and microvascular complications in type 1 diabetes.
    Vaccaro O, Perna AF, Mancini FP, Iovine C, Cuomo V, Sacco M, Tufano A, Rivellese AA, Ingrosso D, Riccardi G.
    Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
    [Abstract] [Full Text] [Related]

  • 9. Thrombin generation in type 2 diabetes with albuminuria and macrovascular disease.
    Ay L, Hoellerl F, Ay C, Brix JM, Koder S, Schernthaner GH, Pabinger I, Schernthaner G.
    Eur J Clin Invest; 2012 May; 42(5):470-7. PubMed ID: 21955218
    [Abstract] [Full Text] [Related]

  • 10. Von Willebrand factor in diabetic angiopathy.
    Kessler L, Wiesel ML, Attali P, Mossard JM, Cazenave JP, Pinget M.
    Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
    [Abstract] [Full Text] [Related]

  • 11. [Thrombomodulin in blood].
    Tanaka A.
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():144-8. PubMed ID: 9513405
    [No Abstract] [Full Text] [Related]

  • 12. Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria.
    Wotherspoon F, Laight DW, Browne DL, Turner C, Meeking DR, Allard SE, Munday LJ, Shaw KM, Cummings MH.
    Diabet Med; 2006 Dec; 23(12):1350-6. PubMed ID: 17116187
    [Abstract] [Full Text] [Related]

  • 13. N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes.
    Grauslund J, Nybo M, Green A, Sjølie AK.
    Scand J Clin Lab Invest; 2010 Oct; 70(6):392-8. PubMed ID: 20575653
    [Abstract] [Full Text] [Related]

  • 14. [Serum hexosamines in diabetic angiopathies].
    Riabchuk OG, Kliachko VR, Tirkina TN, Starosel'tseva LK.
    Probl Endokrinol (Mosk); 1970 Oct; 16(6):14-6. PubMed ID: 5521085
    [No Abstract] [Full Text] [Related]

  • 15. von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII).
    Vischer UM, Emeis JJ, Bilo HJ, Stehouwer CD, Thomsen C, Rasmussen O, Hermansen K, Wollheim CB, Ingerslev J.
    Thromb Haemost; 1998 Dec; 80(6):1002-7. PubMed ID: 9869174
    [Abstract] [Full Text] [Related]

  • 16. Plasma endothelin-1 concentrations in non-insulin-dependent diabetes mellitus and nondiabetic patients with chronic arterial obstructive disease of the lower limbs.
    Mangiafico RA, Malatino LS, Santonocito M, Spada RS.
    Int Angiol; 1998 Jun; 17(2):97-102. PubMed ID: 9754897
    [Abstract] [Full Text] [Related]

  • 17. [Clinical significance of blood thrombomodulin analysis in the diagnosis of diabetic complications].
    Tanaka A, Maezawa H.
    Nihon Rinsho; 1990 Dec; 48 Suppl():401-5. PubMed ID: 1964976
    [No Abstract] [Full Text] [Related]

  • 18. Marked increase of activated factor VII in uremic patients.
    Kario K, Matsuo T, Matsuo M, Koide M, Yamada T, Nakamura S, Sakata T, Kato H, Miyata T.
    Thromb Haemost; 1995 May; 73(5):763-7. PubMed ID: 7482400
    [Abstract] [Full Text] [Related]

  • 19. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
    Zimmermann J, Schramm L, Wanner C, Mulzer E, Henrich HA, Langer R, Heidbreder E.
    Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207
    [Abstract] [Full Text] [Related]

  • 20. Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study.
    Soedamah-Muthu SS, Chaturvedi N, Teerlink T, Idzior-Walus B, Fuller JH, Stehouwer CD, Eurodiab ProspectivE Complications Study Group.
    J Intern Med; 2005 Nov; 258(5):450-9. PubMed ID: 16238681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.